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ABSTRACT
Protein methylation occurs primarily on lysine and
arginine, but also on some other residues, such as
histidine. METTL18 is the last uncharacterized mem-
ber of a group of human methyltransferases (MTases)
that mainly exert lysine methylation, and here we set
out to elucidate its function. We found METTL18 to
be a nuclear protein that contains a functional nu-
clear localization signal and accumulates in nucleoli.
Recombinant METTL18 methylated a single protein
in nuclear extracts and in isolated ribosomes from
METTL18 knockout (KO) cells, identified as 60S ribo-
somal protein L3 (RPL3). We also performed an RPL3
interactomics screen and identified METTL18 as the
most significantly enriched MTase. We found that
His-245 in RPL3 carries a 3-methylhistidine (3MH;
 -methylhistidine) modification, which was absent
in METTL18 KO cells. In addition, both recombi-
nant and endogenous METTL18 were found to be
automethylated at His-154, thus further corroborat-
ing METTL18 as a histidine-specific MTase. Finally,
METTL18 KO cells displayed altered pre-rRNA pro-
cessing, decreased polysome formation and codon-
specific changes in mRNA translation, indicating that
METTL18-mediated methylation of RPL3 is impor-
tant for optimal ribosome biogenesis and function.
In conclusion, we have here established METTL18 as
the second human histidine-specific protein MTase,
and demonstrated its functional relevance.
INTRODUCTION
The transfer of a methyl group from the methyl donor S-
adenosylmethionine (AdoMet) to a biomolecule is a com-
mon biochemical reaction, catalyzed by a number of differ-
ent methyltransferases (MTases) (1). Bioinformatics anal-
ysis has indicated that the human genome encodes more
than 200 AdoMet-dependent MTases (2). Many of these en-
zymes still remain uncharacterized, although the biochem-
ical function of several human MTases has been uncovered
in recent years. The so-called seven -strand (7BS) MTases,
which have a characteristic core fold consisting of seven
-strands, also referred to as the ‘Rossmann-fold’, consti-
tute the largest group of MTases in humans (2,3). These
enzymes methylate a wide range of different substrates, in-
cluding metabolites, lipids, nucleic acids and proteins. The
SET-domain proteins represent the second largest group of
MTases in humans, and they mainly target lysines in pro-
teins (4).
Proteins are subject to a wide range of post-translational
modifications (PTMs). Methylation is a PTM occurring
mainly at lysines and arginines, but other residues, such
as glutamine or histidine, can also be methylated (5–11).
In the case of histidine methylation, which is a relatively
poorly studied PTM, the two nitrogen atoms of the imida-
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zole ring of a histidine can be monomethylated, yielding 1-
methylhistidine or 3-methylhistidine (1MH or 3MH; also
referred to as - or  -methylhistidine, respectively). Both
forms exist in mammals, but only a few methylhistidine-
modified proteins have been firmly established (12–16).
However, recent high-throughput studies have identified
hundreds of candidate histidine-methylated proteins in
mammals, indicating that this modification is widespread
(11,17). Only two histidine-specific protein MTases have so
far been described in eukaryotes. First, the MTase encoded
by open reading frame (ORF) YIL110W in Saccharomyces
cerevisiae was found to mediate the introduction of 3MH at
His-243 in the 60S ribosomal protein L3 (Rpl3), and there-
fore denoted Hpm1 (histidine protein methyltransferase 1)
(10). Second, the human SET-protein SETD3 was recently
identified as the long-sought MTase responsible for intro-
ducing 3MH at His-73 in actin (8,11).
When yeast Hpm1 was discovered in 2010, the orphan
MTase METTL18 (also known as C1orf156) was pin-
pointed as its closest human sequence homolog, and also
suggested as a possible functional ortholog (10). Neverthe-
less, the function of METTL18 remains obscure a decade
later. METTL18 is one of the 11 human members of the
so-called MTase Family 16 (MTF16) (18–20), and we and
others proposed MTF16 as a family of lysine (K)-specific
MTases (KMTs) (18,19). Indeed, KMT activity has now
been reported for nearly all human MTF16 members, but
no studies have focused on METTL18. Furthermore, yeast
Hpm1 and human METTL18 only exhibit a modest se-
quence similarity (31% identity; 50% similarity), compa-
rable to the similarity between two other MTF16 mem-
bers, yeast Efm6 and human METTL21A, which target
different substrates, and are thus not orthologs (21,22).
Moreover, attempts to complement phenotypes of Hpm1-
deficient yeast by the expression of human METTL18 were
unsuccessful (23). On the other hand, human RPL3 was re-
ported as a main METTL18 interactant in pull-down exper-
iments, suggesting that RPL3 may indeed be the target of
METTL18 (18). In conclusion, the function of METTL18
has remained unresolved, requiring further investigation.
The ribosome represents a universally conserved molec-
ular machine that translates the genetic information in
mRNA into a protein sequence. The human ribosome (80S)
consists of four ribosomal RNAs (rRNAs) and 80 proteins,
which are distributed between the small (40S; contains 18S
rRNA) and large (60S; contains 28S, 5.8S and 5S rRNAs)
subunits (24). While 5S rRNA is transcribed from a sepa-
rate gene, the remaining rRNAs are transcribed from a joint
gene in the form of one, long primary transcript (47S pre-
rRNA), which is processed through cleavage and trimming
by several specific ribonucleases to yield the mature 18S,
28S and 5.8S rRNAs (25). Both rRNA and ribosomal pro-
teins contain several different modifications, including nu-
merous methylations (26–28). The assembly and maturation
of the ribosome, occurring primarily within the nucleoli, is a
highly orchestrated process, where timely processing of pre-
cursor rRNAs and insertion of specific rRNA and protein
modifications is essential (29). To fully understand the func-
tional significance of these modifications in the context of
ribosome biogenesis and function, it is necessary to identify
the various enzymes responsible for their introduction.
Since the function of METTL18 has remained unre-
solved, we set out to elucidate various functional aspects
of this enigmatic MTase. We found METTL18 to be a nu-
clear protein, accumulating in nucleoli and containing a nu-
clear localization signal (NLS). Recombinant METTL18
methylated a single protein present in nuclear extract of
human METTL18 KO cells, which was identified by mass
spectrometry (MS) as the ribosomal protein RPL3. Using
both biochemical and cellular approaches, we demonstrated
that METTL18 introduces 3MH at position 245 in RPL3.
Moreover, processing of pre-rRNA and mRNA translation
were both affected by METTL18 ablation.
MATERIALS AND METHODS
Gene cloning and mutagenesis
The plasmid constructs and the strategy to generate them
are described in detail in Supplementary Table S1. In brief,
ORF were amplified by polymerase chain reaction (PCR),
and cloned into indicated vectors by standard ligation-
dependent cloning, or by ligation-independent cloning us-
ing In-Fusion® HD Cloning Plus kit (Takara). Mutations
within ORFs were introduced by site-directed mutagenesis
using PCR splicing by overhang extension (PCR SOEing)
as previously described (30). Sanger sequencing was used to
verify all cloned constructs.
Bioinformatics analysis
Sequence alignments were generated using algorithms em-
bedded in the JalView interface (http://www.jalview.org/)
(31).
Transient transfection of HeLa cells and fluorescence mi-
croscopy
HeLa cells were grown in RPMI 1640 + Gluta-
MAX™ medium (Gibco) supplemented with 10% (v/v)
fetal bovine serum (FBS) (Gibco) and 100 U/ml penicillin-
streptomycin (P/S) (Lonza). HeLa cells were transiently
transfected, using the Lipofectamine® 3000 transfec-
tion kit (Invitrogen), with pEGFP-N1-derived plasmids
(Clontech) encoding human full-length (FL) METTL18
or its variant consisting only of amino acids 233–265 that
contains a putative nuclear localization sequence (NLS),
all fused to the N-terminus of enhanced green fluorescent
protein (EGFP). The FL and NLS METTL18 constructs
were either WT or K250G/R251G-mutated. When indi-
cated, cells were co-transfected with pMRFP-C1-RPL3
plasmid encoding human RPL3 fused to the C-terminus
of monomeric red fluorescent protein (MRFP) (32). After
overnight incubation cells were stained with 1 g/ml DAPI
(Sigma-Aldrich) to visualize the nuclei. Live cells were
imaged using an Olympus FluoView 1000 (I × 81) inverted
confocal fluorescence microscopy system, equipped with
a UPLSAPO 60× NA 1.35 oil objective (Olympus). The
different fluorophores were excited at 405 nm (DAPI), 488
nm (EGFP) and 559 nm (MRFP), and Kalman averaging
(n = 3, sequential) was used to record multichannel images.
The fluorescent signals emitted from EGFP, MRFP and
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Generation of HEK293-derived cell lines for ectopic expres-
sion of ORFs
ORFs encoding GFP alone, or GFP fused to human RPL3,
either WT or R246A/R249A-mutated (RPL3 fused to N-
terminus of GFP) were cloned into the pcDNA5/FRT/TO
plasmid (Thermo Fisher Scientific) under the control of
a doxycycline (Dox)-inducible promoter, similarly as de-
scribed in ref. (32). HEK293-derived, Flp-In™ T-REx™ 293
cells (Thermo Fisher Scientific) were co-transfected with
pOG44 and pcDNA5/FRT/TO-derived plasmids, accord-
ing to manufacturer’s instructions, and selected with 200
g/ml Hygromycin B (Thermo Fisher Scientific). The pool
of surviving cells was maintained in high-glucose DMEM
+ GlutaMAX™ medium (Gibco) supplemented with 10%
FBS and P/S. To test ORF expression, cells were left un-
treated or induced with 1 g/ml Dox for 24 h and then fixed
in cold acetone for 10 min. Cells were visualized by fluores-
cence microscopy after incubation with 1 g/ml Hoechst
33258 (Sigma-Aldrich) to stain the nuclei (ex = 405 nm),
similarly as described in the above section.
Generation of HAP1-derived stable cell lines
HAP1-derived cells were grown in IMDM + Gluta-
MAX™ medium (Gibco) supplemented with 10% FBS and
P/S. HAP1 METTL18 knock-out (KO) cells were gener-
ated as a custom (non-exclusive) project by Horizon Dis-
covery (Austria). The METTL18 gene was disrupted in hap-
loid HAP1 parental cells using CRISPR-Cas9, with guide
RNA designed to target part of the exon located imme-
diately downstream of the Post I motif, which is required
for enzymatic activity of 7BS MTases. Individual clones
were selected by limiting dilution, and frame-shifting events
within the targeted gene were determined by sequencing of
genomic DNA. The METTL18-deficient cell line used in
this study (Horizon Discovery HZGHC000541c002) con-
tains a 2-bp insertion within exon 2, thus generating a
version of the METTL18 protein consisting of the initial
230 amino acids of METTL18 (i.e. truncated 13 amino
acids downstream of the Post I motif), followed by two
residues of out-of-frame sequence and a premature stop-
codon. Complementation of METTL18 KO cells was per-
formed similarly as described previously (33) by transfec-
tion with p3×FLAG-CMV-14-derived plasmids encoding
either WT or D217A-mutated human METTL18, all bear-
ing a C-terminal 3×FLAG-tag. Transfected cells were se-
lected and expanded in medium containing 1 mg/ml ge-
neticin (Gibco). Individual clones of complemented cells
were screened by western blot for the presence of the FLAG-
tag and GAPDH (as loading control), using appropriate an-
tibodies (see western blot analysis section).
Cell fractionation and Western blot analysis
Cells were grown in 10-cm diameter plates until 50–80%
confluent. After washing with phosphate-buffered saline
(PBS), cells were scraped in PBS and centrifuged (5 min,
500 × g). Cell lysis and fractionation into cytoplasmic and
nuclear fractions was performed at 4◦C, using a modified
rapid, efficient and practical method (34). Cell pellets were
lysed on ice, for 2 min, in 300 l Fractionation Buffer (PBS,
supplemented with 0.1% NP-40 and 1% protease inhibitors
cocktail (P8340, Sigma)). The lysate was vortexed and 100
l of whole cell extract (WCE) was transferred to another
tube, which was kept on ice. The remaining lysate was cen-
trifuged (45 s, 16 100 × g) to sediment the nuclei, and 100 l
of the supernatant, designated cytoplasmic fraction (Cyt),
was transferred to a new tube, which was kept on ice. The
rest of the supernatant was discarded, and the nuclear pel-
let was washed twice in 500 l Fractionation Buffer and
centrifuged (45 s, 16 100 × g). After the final centrifuga-
tion, the supernatant was discarded, and the nuclear pellet
was resuspended in 200 l Fractionation Buffer, and desig-
nated nuclear fraction (Nucl). WCE, Cyt and Nucl fractions
were adjusted to contain 5 mM CaCl2 and 1 U/l micro-
coccal nuclease (Thermo Fisher Scientific), then incubated
at room temperature for 6 min, with intensive vortexing ev-
ery minute, and finally placed on ice. Protein concentration
in WCE and fractions was determined using Pierce BCA
Protein Assay Kit (Thermo Fisher Scientific).
Protein (50 g) from WCE, or from Cyt and Nucl frac-
tions (corresponding to the same amount of cells), was
resolved by sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred to a PVDF
Immobilon®-FL transfer membrane (Merck), which was
stained with Ponceau S and blocked using Odyssey® Block-
ing Buffer (TBS) (LI-COR) diluted 1:1 (v/v) in TBS. The
membrane was then incubated with primary antibodies:
mouse anti-FLAG (F1804, Sigma-Aldrich), rabbit anti-
GAPDH (ab9485, Abcam), or rabbit anti-H3 (ab1791,
Abcam), diluted in Odyssey® Blocking Buffer mixed 1:1
(v/v) with TBS, containing 0.05% Tween-20. The primary
antibodies were detected with LI-COR secondary anti-
bodies coupled with infrared fluorescent dyes, either goat
anti-mouse IRDye® 680RD, or goat anti-rabbit IRDye®
800CW, according to the manufacturer’s instructions and
visualized using LI-COR Odyssey CLx Imaging System.
When necessary, the same membrane was re-probed with
different primary and secondary antibodies, without strip-
ping. Precision Plus Protein Dual Color Standards (Bio-
Rad), or Cameleon Duo Pre-stained Protein Ladder (LI-
COR), were used to evaluate the size of polypeptides visu-
alized by western blot. The signal intensities of the individ-
ual proteins were quantified using the software package of
the Odyssey Imaging System. The METTL18-FLAG sig-
nal from the Cyt or Nucl fractions was calculated as the
percentage of the total (Cyt + Nucl) signal.
Expression and purification of recombinant His-tagged
METTL18
The ORF encoding human METTL18, or a METTL18
variant with its initial 94 amino acids deleted (94
METTL18), either WT, H154A- or D217A-mutated, was
cloned into the pET28a plasmid (Novagen) to contain N-
terminal 6×His-tag. Plasmids were transformed into Es-
cherichia coli strain BL21-CodonPlus (DE3)-RIPL (Agi-
lent) and protein expression was induced overnight with 0.1
mM IPTG at 18◦C. Isolation of 6×His-tagged proteins was
performed at 4◦C. Bacteria were lysed in Lysis Buffer 1 (50
mM Tris–HCl pH 7.4, 500 mM NaCl, 1% Triton X-100, 5%
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plete™ (EDTA-free) protease inhibitor cocktail (Roche) and
10 U/ml Benzonase nuclease (Sigma-Aldrich), and lysates
were clarified by centrifugation (30 min, 45 000 × g).
Cleared lysates were applied to Ni-NTA-agarose (Qiagen)
equilibrated in Lysis Buffer 1. The resin was washed sequen-
tially with Wash Buffer (50 mM Tris–HCl pH 7.4, 5% glyc-
erol, 25 mM imidazole) supplemented with 0.5 M NaCl,
then with Wash Buffer supplemented with 2.0 M NaCl, and
finally again with Wash Buffer supplemented with 0.5 M
NaCl. His-tagged proteins were eluted using Wash Buffer
supplemented with 0.5 M NaCl and 200 mM imidazole, and
buffer-exchanged to Storage Buffer (50 mM Tris–HCl pH
7.4, 100 mM NaCl, 10% glycerol) using centrifugal concen-
trators (Sartorius, 50 kDa cut-off). Proteins were aliquoted
and stored at −20◦C. Proteins were >90% pure as assessed
by SDS-PAGE and Coomassie Blue staining. Protein con-
centration was determined using Pierce BCA Protein Assay
Kit.
In vitro methyltransferase assay using [3H]AdoMet
To test MTase activity of recombinant METTL18 on cel-
lular material, 10 l reactions were assembled on ice con-
taining: 1× Storage Buffer, ∼1 g of recombinant 94
METTL18 (WT, H154A- or D217A-mutated), 0.5 Ci of
[3H]AdoMet (Perkin-Elmer) ([AdoMet]total = 0.64 M,
specific activity = 78.2 Ci/mmol) and ∼50 g protein from
WCE, Cyt or Nucl fractions. Reactions were incubated at
30◦C for 1 h, and then analyzed by SDS-PAGE and flu-
orography, similarly as previously described (35). When
METTL18 activity was tested on ribosomes, ∼12 g pro-
tein from isolated ribosomes was added and after 1 h in-
cubation at 30◦C, the 10 l reactions were supplemented
with 2 g RNase A, and incubated at room temperature
for further 15 min, before SDS-PAGE analysis. Typically, all
fluorography experiments were performed three times, with
similar results, and data from a representative experiment
are shown.
Isolation of crude ribosome fraction
Cells were grown in 15-cm diameter plates until ∼80% con-
fluent. After washing with PBS, cells were scraped in PBS,
centrifuged (5 min, 500 × g) and frozen at −80◦C until
needed. Ribosome isolation was performed at 4◦C, using
a previously published protocol (36), with some modifica-
tions. Typically, cells from three plates were briefly thawed
on ice, and lysed on ice, for 10 min, in 600 l Ribosome Ly-
sis Buffer (50 mM Tris–HCl, pH 7.4, 250 mM KCl, 5 mM
MgCl2, 250 mM sucrose, 1% Triton X-100, 1% protease
inhibitor cocktail (P8340, Sigma-Aldrich)). The lysate was
centrifuged (10 min, 1000 × g) to sediment the nuclei, and
then the supernatant was further clarified by centrifugation
(10 min, 16 100 × g). The clarified supernatant was adjusted
to the final concentration of 0.5 M KCl, using 2 M KCl
added in small portions. The adjusted suspension, contain-
ing ribosomes, was subsequently carefully layered on top of
1.2 mL Sucrose Cushion (50 mM Tris-HCl, pH 7.4, 500 mM
KCl, 5 mM MgCl2, 1 M sucrose) prepared in polycarbon-
ate centrifuge tubes (13 × 51 mm, Beckman-Coulter), and
centrifuged at 4◦C (4 h, 250 000 × g), in an Optima Max
ultracentrifuge using a MLS-50 rotor (Beckman-Coulter).
The supernatant and the sucrose cushion were carefully re-
moved, the ribosomal pellet was briefly rinsed with 250 l
cold Ribosome Wash Buffer (50 mM Tris–HCl, pH 7.4, 500
mM KCl, 5 mM MgCl2) and finally resuspended by inten-
sive pipetting in 200–400 l Ribosome Storage Buffer (50
mM Tris–HCl, pH 7.4, 25 mM KCl, 5 mM MgCl2). Ribo-
some solution was then cleared from undissolved particles
by centrifugation (10 min, 16 100 × g), aliquoted and frozen
at −80◦C. Typically, isolated ribosomes had an A260/A280
ratio of ∼1.8. Ribosomes were quantified by RNA content,
assuming that OD260 = 14 corresponds to 1 mg/ml of ribo-
somes, i.e. ∼0.5 mg/ml of ribosomal proteins (36).
GFP-trap immunoprecipitation
Flp-In™ T-REx™ 293-derived cells engineered to ectopi-
cally express RPL3-GFP or GFP, under Dox-induced pro-
moter, were incubated with 1 g/ml Dox for 24 h, har-
vested and lysed at 4◦C, for 15 min, in RIPA buffer (Sigma-
Aldrich), supplemented with 1 mM phenylmethylsulfonyl
fluoride (Sigma-Aldrich) and 1× Complete™ (EDTA-free)
protease inhibitor cocktail. The lysate was cleared at 4◦C
by centrifugation (10 min, 16 100 × g), diluted in Dilution
Buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.5 mM
EDTA) and subjected to immunoprecipitation using GFP-
Trap® agarose beads (Chromotek) at 4◦C, for 2 h. After
washing the beads with the Dilution Buffer, samples were
further processed for MS analysis.
MS identification of proteins interacting with GFP-fusion
proteins
Proteins isolated by GFP-Trap® immunoprecipitation, us-
ing RPL3-GFP (bait) or GFP only (control), were eluted
and digested by adding 25 l of 2 M urea, supplemented
with 1 mM dithiothreitol (DTT) and 5 ng/l trypsin. The
resulting peptides were alkylated by adding 5 mM iodoac-
etamide, then desalted using StageTips (37) and analyzed
using EASY-nLC 1200 system coupled to a QExactive HF-
X mass spectrometer (Thermo Fisher Scientific) operat-
ing in a data-dependent acquisition mode (38). MS files
were analyzed with MaxQuant (v1.6.0.1) (39), using the
default settings except for the following variable modifi-
cations: mono-methylation (Lys, Arg, His), di-methylation
(Lys, Arg) and tri-methylation (Lys). Proteins were quanti-
fied using the MaxLFQ algorithm (40). All analysis of pro-
teomics data was performed using Perseus (version 1.6.5.0)
(41).
MS analysis of proteins from subcellular fractions
Proteins present in Nucl/Cyt fractions and isolated ribo-
somes, or R246A/R249A-mutated RPL3-GFP isolated by
GFP-Trap® immunoprecipitation, were resolved by SDS-
PAGE, stained with Coomassie, and the portion of gel con-
taining protein of interest was excised and subjected to
in-gel proteolytic digestion using trypsin (Promega), chy-
motrypsin (Roche), Lys-C (Roche) or proteinase K (Sigma-
Aldrich). Peptides resulting from proteolytic digestion were
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ZipTips, and analyzed by liquid chromatography system
coupled to a QExactive Hybrid Quadrupole-Orbitrap Mass
Spectrometer (Thermo Fisher Scientific), similarly as de-
scribed previously (35).
MS data were analyzed using in-house maintained hu-
man protein sequence databases using SEQUEST™ and
Proteome Discoverer™ (Thermo Fisher Scientific), simi-
larly as described previously (42). MS/MS spectra of pep-
tides corresponding to methylated RPL3, were manually
searched by Qual Browser (v2.0.7).
Amino acid analysis by LC-MS/MS
Cell pellets (from ∼80% confluent 15-cm diameter plates)
or dried ribosomes (an equivalent of ∼0.6 mg of riboso-
mal proteins) were dissolved in 0.6–0.8 ml 6 M ultrapure
HCl (Thermo Fisher Scientific) and incubated under vac-
uum at 120◦C, for 24 h, using 1 ml vacuum hydrolysis tubes
(Thermo Fisher Scientific). Alternatively, ribosomes were
incubated at room temperature, for 15 min, with 0.2 mg/ml
RNase A, then resolved by SDS-PAGE, and then the region
of Coomassie Blue-stained gel corresponding to RPL3 was
cut out from gel, chopped, vacuum-dried and finally trans-
ferred to 1 ml vacuum hydrolysis tubes for HCl-hydrolysis,
as described above. After 24 h of HCl-hydrolysis, the result-
ing solutions were transferred to plastic tubes and evapo-
rated overnight, at 65◦C. Dry pellets were then dissolved in
2 ml ultrapure H2O, the solutions were filtered (0.45 m)
and again evaporated at 65◦C. The remaining dry material
was then analyzed by Bevital (Bergen, Norway) using LC-
MS/MS (analysis platform C), to detect and quantify histi-
dine, 1MH and 3MH.
Total RNA extraction and analysis by northern blot
Total RNA was extracted using TRI Reagent (Sigma-
Aldrich). The aqueous phase was further extracted with
phenol-chloroform-isoamylic alcohol (25:24:1; Sigma-
Aldrich), and then with chloroform. Total RNA from
the aqueous phase was recovered after precipitation with
2-propanol, and then rinsed twice in 70% ethanol. Total
RNA was denatured for 10 min at 70◦C, and analyzed by
electrophoresis using 1.2% agarose gels, containing 1.2%
formaldehyde and Tri/Tri buffer (30 mM triethanolamine,
30 mM tricine, pH 7.9) (3 g total RNA/lane). RNA was
then passively transferred to a Hybond N+ nylon mem-
brane (GE Healthcare). To analyze small RNAs, total RNA
was separated by electrophoresis using 6% polyacrylamide
gels (acrylamide:bisacrylamide 19:1), containing 7 M urea
and Tris-borate EDTA buffer and electro-transferred to a
nylon membrane. After UV crosslinking, nylon membranes
were pre-hybridized for 1–2 h, at 45–48◦C, in 6× SSC, 5×
Denhardt’s solution, 0.5% SDS and 0.9 g/ml of tRNA.
Membranes were incubated overnight with 5’-radiolabeled
oligonucleotide probes, whose sequences are indicated in
Supplementary Table S2. After hybridization, membranes
were washed twice, for 10 min, in 2× SSC, 0.1% SDS
and once in 1× SSC, 0.1% SDS and then exposed to
PhosphorImager Screens (Fuji), which were then scanned
using the Typhoon Trio Imager System (GE Healthcare),
and quantified using the MultiGauge software.
Measurement of polysome profiles
Cells were incubated for 10 min in Dulbecco’s-modified Ea-
gle’s medium (DMEM) containing 100 g/ml cyclohex-
imide (CHX) (Sigma-Aldrich). All subsequent steps were
performed in the presence of 100 g/ml CHX. Cells were
collected by centrifugation at 4◦C (5 min, 300 × g) after
treatment with trypsin and CHX. Cell pellets were mechan-
ically disrupted with a Dounce homogenizer in 800 l of
buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM
MgCl2, 0.5 mM DTT) containing CHX. The lysate was
cleared from nuclei by centrifugation at 4◦C (10 min, 1000 ×
g), and the upper cytoplasmic fraction was further clarified
by two successive centrifugations at 10 000 × g, 5 min each.
An aliquot containing 1 mg protein was loaded on a 10–50%
(w/w) sucrose gradient prepared in buffer A, which was
generated with a Gradient Master former (BioComp In-
struments). The gradient was centrifuged at 4◦C (2 h 15 min,
36 000 rpm), using a SW41Ti rotor (Optima L100XP ultra-
centrifuge; Beckman-Coulter), and the fractions were col-
lected with a Density Gradient Fractionation System (Tele-
dyne Isco) with continuous reading of OD254nm.
Ribosome profiling
Ribosome profiling libraries of HAP1 cells were generated
in duplicates (WT cells) or triplicates (METTL18 KO cells).
Cells were washed with ice-cold PBS, flash frozen in liq-
uid nitrogen and transferred on ice. A total of 400 l Lysis
Buffer 2 (10 mM Tris–HCl pH 7.5, 100 mM NaCl, 5 mM
MgCl2, 1% Triton X-100, 0.5 mM DTT, 0.5% sodium de-
oxycholate (w/v), 100 g/ml CHX) was dripped onto the
cells, which were scraped after lysis buffer had thawed. The
lysate was cleared from nuclei by centrifugation at 4◦C (5
min, 10 000 × g). Subsequently, ribosome protected frag-
ments were generated by digesting 10 A260 units of the
cleared lysate with 900 U RNase I (Thermo Fisher) at 22◦C,
for 1 h. The reaction was stopped by addition of 15 l SU-
PERase In RNase inhibitor (Thermo Fisher) and loaded
on a 10–50% (w/v) sucrose gradient prepared in Gradient
Buffer (50 mM Tris–HCl pH 7.5, 50 mM NH4Cl, 12 mM
MgCl2, 0.5 mM DTT, 100 g/ml CHX), and centrifuged at
4◦C (3 h, 35 000 rpm), using a TH-641 rotor (Thermo Sci-
entific). The 80S ribosome fraction was collected and total
RNA isolated. Subsequently, RNA was separated by elec-
trophoresis using a 15% polyacrylamide gel containing 8 M
urea (1 × TBE buffer), and 28–32 nt ribosome footprints
were extracted from the gel. Finally, libraries were gener-
ated as described (43), but using adenylated 3′-adapters that
contained four randomized nucleotides to reduce ligation
biases (44). Libraries were mapped to the hg38 transcrip-
tome (UCSC knownGene), and subsequent analysis was
performed using a custom script. A-site codon occupancy
was determined as previously described (45), while exclud-
ing the first 15 nt of each ORF to reduce position-specific
biases. About 29–31 nt long reads starting in the 0-frame
were used, and the A-site defined as positions 15–17 nt from
the start of the read. Occupancy was normalized to the ad-
jacent codons in the +1, +2 and +3 positions. Ribosome oc-
cupancy at the +1 position (18–20 nt from the start of the
read) was normalized by occupancy in the +2, +3 and +4
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a log2 fold change threshold of 0.5, was used for differential
gene translation analysis of ribosome protected fragments
(46). Gene ontology (GO) term analysis was performed us-
ing Gorilla (47).
Statistical analysis
The independent two-sample Student’s t-test was used to
evaluate the probability (p-value) that the means of two
populations are not different.
RESULTS
Human METTL18 is an evolutionarily conserved 7BS
MTase containing hallmark motifs
The function of METTL18 has hitherto remained elu-
sive, and it has been unclear whether METTL18 is an
ortholog of yeast Hpm1. Thus, we have taken an unbi-
ased approach to elucidate the role of this enzyme. The
crystal structure of human METTL18 in complex with S-
adenosylhomocysteine (PDB ID: 4RFQ) shows the pres-
ence of seven -strands forming a twisted -sheet, charac-
teristic of 7BS MTases. Protein sequence searches indicated
that putative METTL18 orthologs are present in all eukary-
otic organisms, including animals, fungi and plants (Supple-
mentary Figure S1). An alignment of METTL18 sequences
from various species revealed conserved motifs that are hall-
marks of 7BS MTases (Motif I, Post I and Motif II), as well
as the so-called ‘DXXY-motif‘ (consensus D/E-X-X-Y/F)
shared by MTF16 members (19). While the MTase domain
of METTL18 is well conserved, its N-terminal region is not,
and can vary in size, being particularly short in some organ-
isms, such as Caenorhabditis elegans (Supplementary Figure
S1), indicating that it may not be strictly required for enzy-
matic activity.
METTL18 contains a non-classical NLS and localizes to nu-
cleoli
To elucidate the function of METTL18, we studied its in-
tracellular localization. For this, HeLa cells were trans-
fected to transiently express a METTL18-GFP fusion pro-
tein. Live cell imaging revealed that METTL18-GFP was
present both in the cytoplasm and the nucleus, but accu-
mulated in the nucleus, particularly in nuclear foci rem-
iniscent of nucleoli. Indeed, these foci co-localized with
RPL3, which is known to accumulate in nucleoli and has
been used as a marker for this organelle (Figure 1A and B)
(32,48). Nuclear proteins often contain a positively charged
NLS, which confers their nuclear localization. We found
that the sequence PDVKRCR (amino acids 247–253 in
METTL18), which is localized to a region of undeter-
mined three-dimensional structure, matched the consen-
sus of Class 2 NLSs (P/R-X-X-K-R-(ˆDE)-K/R; X, any
amino acid; ˆDE, any amino acid except D or E) (49), sug-
gesting it may represent a putative NLS. This sequence
is highly conserved in vertebrates, but not in other ani-
mals, fungi or plants (Supplementary Figure S1) and to
test whether it represents a functional NLS, two positively
charged residues (K250 and R251) were replaced by glycine
(K250G/R251G) in a METTL18-GFP construct. Mutant
METTL18-GFP did not show accumulation in the nu-
cleus, in contrast to the WT protein (Figure 1A). Moreover,
a fusion protein between GFP and the NLS-containing
portion of METTL18 (amino acids 233–265) accumulated
preferentially in the nucleus, but was excluded from the
nucleoli (Figure 1A and B), whereas the corresponding
K250G/R251G-mutated protein showed uniform distribu-
tion between the nucleus and the cytoplasm (Figure 1A).
To independently confirm the nuclear localization of
METTL18 observed by microscopy, HAP1 cells with
METTL18 gene KO were complemented with ectopically
expressed METTL18-FLAG (Supplementary Figure S2),
and then fractionated into cytoplasmic and nuclear frac-
tions. Immunoblotting, using anti-FLAG antibodies, re-
vealed that ∼60% of METTL18-FLAG was associated with
the cytosolic fraction, while ∼40% was associated with the
nuclear fraction (Figure 1C). In summary, our results show
that human METTL18 contains a Class 2 NLS that con-
fers its localization to the nucleus, where it accumulates in
nucleoli.
METTL18 is a protein methyltransferase
Several human MTases can, in the recombinant form, di-
rectly methylate their respective substrates in a cell extract.
Previously, we have successfully used extracts from MTase
KO cells, where the relevant substrates are found in the
unmethylated form (33,50–52). Thus, we set out to inves-
tigate recombinant METTL18, containing an N-terminal
6×His-tag, for such activity. We were unable to express
full-length METTL18 in E. coli. However, a variant lack-
ing the initial 94 residues (94 METTL18), thereby match-
ing the size of the METTL18 homolog from C. elegans,
was efficiently expressed and purified. This recombinant,
truncated METTL18 protein was tested for MTase activ-
ity using a cell extract from HAP1 METTL18 KO cells
in the presence of [3H]AdoMet, allowing the detection of
[3H]-methylated proteins by fluorography as distinct bands
in SDS-PAGE. Also, we performed such experiments with
the isolated cytoplasmic or nuclear fractions from these
cells (Figure 2A). In these experiments, we observed sev-
eral [3H]-labeled proteins but their methylation was typi-
cally METTL18-independent, likely originating from hu-
man MTases present in the extract. The exception was
a ∼36 kDa protein representing automethylated recombi-
nant METTL18, and a ∼46 kDa protein, whose methyla-
tion was dependent on the added recombinant METTL18
(Figure 2A). The [3H]-labeled ∼46 kDa protein was ob-
served both in the cytoplasmic and the nuclear fractions,
but could not be detected above the strong METTL18-
independent background in the WCE (Figure 2A). We also
noticed that the ∼46 kDa protein was present in the in-
soluble part of the nuclear fraction, while the ∼36 kDa
band, i.e. auto-methylated METTL18, was soluble (Sup-
plementary Figure S3). Reassuringly, the ∼46 kDa pro-
tein was not methylated by the putatively inactive D217A-
mutated METTL18 (Figure 2B and Supplementary Fig-
ure S1). (Note: Asp-217, which is part of motif Post I,
is putatively necessary for AdoMet-binding, and the cor-
responding residue was shown to be required for activity
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Figure 1. Human METTL18 contains a functional NLS and accumulates in nucleoli. (A) Intracellular localization of METTL18-GFP fusion pro-
teins. HeLa cells were transiently transfected with plasmids encoding variants of METTL18-GFP (METTL18 fused to the N-terminus of EGFP), either
METTL18 full length (FL) or a fragment consisting of amino acids 233–265 (NLS), and either WT or K250G/R251G-mutated. Shown are representa-
tive live cell images of GFP (green) and nuclear (DAPI; blue) staining. (B) Intracellular localization of METTL18-GFP and RFP-RPL3 fusion proteins.
HeLa cells were transiently co-transfected with plasmids encoding RFP-RPL3 and METTL18-GFP variants, either FL or NLS. Shown are representative
live cell images of GFP (green), RFP (red) and nuclear (DAPI; blue) staining. (C) Subcellular distribution of METTL18-FLAG. METTL18 KO HAP1
cells were complemented with METTL18 by stable transfection with a plasmid encoding METTL18-FLAG (for details see Supplementary Figure S2).
Cells were lysed, and the WCE was fractionated into cytoplasmic (Cyt) and nuclear (Nucl) fractions, which were analyzed by SDS-PAGE and western
blotting (WB:), and probed with anti-FLAG antibody. Expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and histone H3 is shown as
loading and specificity control for Cyt and Nucl fractions, respectively. Shown are results from a representative experiment (top), and the quantitation of
METTL18-FLAG signal associated with Cyt and Nucl fractions, based on results from five independent experiments (bottom). Shown are average values,
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Figure 2. Recombinant METTL18 methylates a nuclear-associated protein in vitro. (A) METTL18-dependent protein methylation in HAP1 METTL18
KO cell extract. Cells were lysed and the WCE was fractionated into cytoplasmic (Cyt) and nuclear (Nucl) fractions. A total of 50 g of protein from WCE,
or the corresponding amount from the indicated fractions, was incubated with [3H]AdoMet (0.5 Ci) and 94 METTL18 (3 M), and then analyzed
by SDS-PAGE and transferred to a membrane. Incorporation of [3H]-methyl into proteins was visualized by fluorography (top) of a Ponceau S-stained
membrane (middle), which was additionally probed for expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and histone H3 (bottom)
as loading and specificity controls for Cyt and Nucl fractions, respectively. Red arrow indicates METTL18-dependent methylation of ∼46 kDa protein
present in Nucl and Cyt fractions. (B) D217A mutation of METTL18 abrogates its enzymatic activity. A total of 40 g of protein from nuclear fraction of
KO cells was incubated with [3H]AdoMet and 94 METTL18, either WT or D217A-mutated and [3H]-methyl incorporation into proteins was visualized
by fluorography (top) as in (A). Ponceau S-stained membrane (bottom) is shown as loading control. (C) The ∼46 kDa protein present in nuclear fraction
is nearly fully methylated in HAP1 WT cells. A total of 40 g of protein from nuclear fraction of WT or KO cells was incubated with [3H]AdoMet and
94 METTL18, and [3H]-methyl incorporation into proteins was visualized by fluorography (top) as in (A). Ponceau S-stained membrane (middle) and
expression of histone H3 (bottom) are shown as loading controls.
that methylation of the ∼46 kDa protein is directly cat-
alyzed by METTL18, rather than by a contaminating E.
coli–derived MTase. Finally, the ∼46 kDa protein did not
become methylated when a nuclear fraction from HAP1
WT, rather than METTL18 KO cells, was used (Figure 2C),
indicating that it represents a bona fide METTL18 sub-
strate that is fully methylated in cells expressing endogenous
METTL18.
Identification of RPL3 as target of METTL18
To identify the ∼46 kDa protein that exhibited strong,
METTL18-dependent methylation, the insoluble part of
the nuclear fraction from HAP1 cells was resolved by SDS-
PAGE and the region of the gel matching the ∼46 kDa
protein was excised, trypsin-digested, and its protein con-
tent analyzed by MS. Several nuclear proteins were identi-
fied in the relevant region (Supplementary Table S3). Strik-
ingly, one of the top hits was RPL3, the counterpart of yeast
Rpl3, the reported target of yeast Hpm1 (10). RPL3 was
also found among the top hits found in the ∼46 kDa re-
gion of the cytoplasmic fraction (Supplementary Table S4).
Taken together, this suggests that RPL3 is a target of human
METTL18.
A previous interactomics experiment, using tagged
METTL18 as bait, identified RPL3 as a main interactant
(18). To further investigate the potential interaction be-
tween RPL3 and METTL18, we used a HEK-293-derived
cell line to ectopically express a RPL3-GFP fusion protein
under the control of a doxycycline-inducible promoter, and
observed that RPL3-GFP was enriched in nucleoli (Sup-
plementary Figure S4). We affinity purified RPL3-GFP
from these cells using a GFP-affinity resin, and the co-
purifying proteins were quantified by MS, and compared
to those isolated from a cell line overexpressing GFP only,
thereby identifying proteins that specifically interacted with
RPL3, and excluding proteins binding to the beads or the
GFP affinity tag. Notably, we found that there were two
MTases among the 74 proteins that were most strongly
(>16-fold) enriched by RPL3, namely METTL18 and the
tRNA methyltransferase TARBP1, further corroborating
that METTL18 and RPL3 interact (Figure 3A; Supplemen-
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Figure 3. METTL18 interacts with RPL3 in cells and methylates ribosomal RPL3 in vitro. (A) RPL3 interactome. Flp-In™ T-REx™ 293 cells, expressing
GFP or RPL3-GFP under doxycycline-inducible promoter, were treated for 24 h with doxycycline (1 g/ml). GFP and RPL3-GFP were isolated using
GFP-Trap®, trypsin-digested and analyzed by MS to identify co-purifying proteins. Volcano plot represents proteins enriched by RPL3-GFP versus GFP
alone. The solid curved line represents the significance cut-off (FDR = 0.01 and s0 = 0.1). The RPL3 (bait), METTL18 and TARBP1 (interactants) are
indicated, while other identified proteins (n = 1576) are listed in Supplementary Table S5. Strongly (>16-fold) enriched proteins (n = 74) are indicated by
the dashed rectangle, and are listed in Supplementary Table S6. (B and C) Recombinant METTL18 methylates ribosomal RPL3 in vitro. (B) METTL18
WT, but not the inactive mutant (D217A), methylates ribosomal RPL3. A total of 12 g of ribosomal proteins isolated from HAP1 METTL18 KO cells
was incubated with [3H]AdoMet (0.5 Ci) and 94 METTL18 (3 M), either non-mutated or D217A-mutated and then analyzed by SDS-PAGE and
transferred to a membrane. Incorporation of [3H]-methyl into proteins was visualized by fluorography (top) of a Ponceau S-stained membrane (bottom)
shown as loading control. Arrows show the positions of RPL3, RPL4 and METTL18. (C) Ribosomal RPL3 isolated from WT cells is nearly fully methy-
lated. 12 g of ribosomal proteins isolated from HAP1 WT or METTL18 KO cells was incubated with [3H]AdoMet and 94 METTL18, and analyzed as
in (A). Incorporation of [3H]-methyl into proteins was visualized by fluorography (top), and the Ponceau S-stained membrane (bottom) shown as loading
control.
bind RNA (54), one may speculate that the observed inter-
action between RPL3 (which also is an RNA-binding pro-
tein) and TARBP1 is indirect and RNA-mediated.
We were unable to show methylation of recombinant
RPL3 by recombinant METTL18 in vitro, and to ob-
tain more direct evidence that RPL3 is methylated by
METTL18, we isolated ribosomes from HAP1 METTL18
KO cells and used those, together with [3H]AdoMet and re-
combinant METTL18, as substrate in an in vitro MTase re-
action. We found that a single band, identified by MS as
RPL3, was indeed [3H]-methylated by METTL18 WT, but
not by the catalytically inactive METTL18 mutant, D217A
(Figure 3B). Moreover, in vitro methylation of RPL3 was
only observed using ribosomes from METTL18 KO cells,
and not with WT ribosomes (Figure 3C), suggesting that
RPL3 is nearly fully methylated in WT cells. Further-
more, ribosomes isolated from WT and METTL18 KO cells
showed similar amounts of RPL3, indicating that lack of
METTL18 does not impair RPL3 incorporation into ribo-
somes (Figure 3C).
Human METTL18 methylates ribosomal RPL3 at His-245
To further investigate METTL18-dependent methylation of
RPL3 in cells, we digested ribosomal RPL3 with various
proteases, followed by MS analysis in search of methylated
RPL3-derived peptides. No methylated peptide could be
identified when RPL3 was digested with commonly used
proteases, such as trypsin or chymotrypsin, while diges-
tion with Lys-C generated peptide KLPRKTHRGLRK
(residues 239–250) that was found monomethylated in
HAP1 WT cells, but the exact localization of the methyl
group within this peptide could not be resolved by MS/MS
analysis (Supplementary Figure S5 and data not shown).
However, digestion of RPL3 with proteinase K generated
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was detected as fully monomethylated in WT cells, but
completely unmethylated in METTL18 KO cells (Figure
4A). MS/MS analysis of this peptide revealed His-245 as
the site of monomethylation (Figure 4B). Importantly, in
KO cells complemented with METTL18-FLAG (Supple-
mentary Figure S2), methylation of His-245 was largely
restored, while in KO cells complemented with D217A-
mutated METTL18-FLAG, His-245 remained completely
unmethylated (Figure 4A).
Our attempts to detect RPL3 methylation by MS
were initially (prior to using proteinase K) unsuccess-
ful. We suspected that the high number of Lys and Arg
residues in the sequence surrounding the putative methy-
lation site His-245, (corresponding to the Hpm1 target
site His-243 in yeast Rpl3) was unfavorable regarding
charge state and/or protease digestion. Thus, we gener-
ated HEK-293-derived cells that ectopically expressed a
R246A/R249A-mutated RPL3-GFP fusion protein from
a doxycycline-inducible promoter (Supplementary Figure
S4), and then isolated the mutated RPL3-GFP using
GFP affinity resin. R246A/R249A-mutated RPL3-GFP
was then subjected to digestion with Lys-C, and analyzed by
MS. We identified the peptide THAGLAK (residues 244–
250 of R246A/R249A-mutated RPL3) and found it to be
∼90% monomethylated at His-245 (Figure 4C and D). This
further corroborates His-245 as the METTL18 target site,
and also indicates that METTL18 shows some tolerance for
amino acid substitutions in the vicinity of this site.
METTL18 mediates 3MH modification of RPL3
Next, we set out to determine which isomer of methylhis-
tidine, 1MH or 3MH, is introduced by METTL18. To this
end, we isolated total and ribosomal proteins from WT and
METTL18 KO HAP1 cells, and then subjected these to acid
hydrolysis into amino acids, which were analyzed and quan-
titated by LC-MS/MS. For total protein, WT and KO cells
showed no significant differences in the content of 1MH and
3MH (Figure 5A and data not shown). For the ribosomes,
however, the level of 3MH was dramatically reduced in the
KO relative to the WT, while 1MH was not detected (Fig-
ure 5A and data not shown). Since we had already identified
RPL3 as target of METTL18, we determined the 3MH con-
tent specifically in ribosome-associated RPL3. Clearly, the
relative content of 3MH was much higher (>10×) in iso-
lated RPL3 compared to bulk ribosomes, directly demon-
strating that RPL3 is 3MH-modified. Moreover, 3MH was
virtually absent in RPL3 from METTL18 KO cells, and
was partially restored by complementation with enzymat-
ically active METTL18, but not by the enzymatically in-
active mutant (Figure 5B). In summary, the above results
demonstrate that RPL3 contains 3MH, and that this mod-
ification depends on the enzymatic activity of METTL18.
METTL18 is automethylated at His-154
Fluorography experiments showed that recombinant
METTL18 is intensely [3H]-labeled when incubated with
[3H]AdoMet (Figures 2 and 3), indicating automethylation.
To examine whether automethylation also occurs during
METTL18 expression in bacteria, and to determine the
modified site(s), recombinant METTL18 was analyzed by
MS in search for methylated peptides. Indeed, the peptide
SFSSHSDLITGVYEGGLK, corresponding to residues
150–167 of METTL18, was found to be almost fully
monomethylated in WT recombinant METTL18 (>95%),
but not in its D217A-mutated counterpart, where it was
completely unmethylated (Figure 6A). MS/MS analysis
revealed His-154 of METTL18 as the site of methylation
(Figure 6B). Importantly, we found that the endogenous
METTL18 that was pulled down by RPL3-GFP during
anti-GFP affinity purification (Figure 3A), was exclusively
detected as the monomethylated (at His-154) form (Figure
6A and Supplementary Figure S6), demonstrating that this
modification occurs in human cells, and not only during
expression/purification of recombinant METTL18 from
E. coli.
Conceivably, the observed automethylation at His-154
may play a role in regulating or optimizing METTL18 ac-
tivity. To investigate the importance of residue His-154 for
METTL18 function, we generated a corresponding mu-
tation, H154A and tested the MTase activity of the mu-
tant protein by the fluorography-based assay, using the nu-
clear fraction from HAP1 METTL18 KO cells as source
of unmethylated RPL3. We observed that H154A-mutated
METTL18 was automethylated to a similar extent as the
WT enzyme, but the methylation of the ∼46 kDa sub-
strate, i.e. RPL3, was strongly reduced (Figure 6C). This
indicates that automethylation of METTL18 can occur at
sites other than His-154 (at least in the H154A-mutated
protein), but that the integrity of His-154 is required for
METTL18-mediated methylation of RPL3. In summary,
our results show that METTL18 is stoichiometrically au-
tomethylated at His-154, and suggest that such automethy-
lation may modulate METTL18 activity.
METTL18 ablation affects early stages of pre-rRNA pro-
cessing
METTL18 was found to co-localize with the ribosomal
protein RPL3 in nucleoli (Figure 1). This suggested that
METTL18-mediated methylation of RPL3 may occur dur-
ing ribosomal biogenesis in nucleoli, and potentially play
an important role in this process. Ribosome biogenesis
involves extensive processing of rRNA precursors (pre-
rRNAs) into mature rRNA. The 18S, 5.8S and 28S rRNAs
originate from the same primary transcript, 47S pre-rRNA,
which is cleaved by various endoribonucleases at specific
cleavage sites located within external transcribed spacers
(5′ETS and 3′ETS) and internal transcribed spacers (ITS1
and ITS2; Figure 7A; reviewed in (25)). Various cleavage
products are further trimmed from both ends by exoribonu-
cleases to produce the mature rRNAs (Figure 7A). After
rapid cleavage at distal sites A’ and 02, which gives rise to
45S pre-rRNA, various intermediates are formed, deter-
mined by the relative efficiency of endonuclease cleavage
at various sites (55). We therefore set out to investigate the
effect of METTL18 ablation on pre-rRNA processing. To
this end, we isolated total RNA from WT and METTL18
KO HAP1 cells, and analyzed it by gel electrophoresis and
Northern blotting. Using specific probes, we detected var-
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Figure 4. Human RPL3 is monomethylated at His-245 by METTL18 in cells. (A) Complementation of METTL18 KO cells with METTL18 restores
monomethylation of RPL3 at His-245. Ribosomes isolated from HAP1 WT, METTL18 KO or KO cells expressing FLAG-tagged METTL18, either non-
mutated or D217A-mutated (see Supplementary Figure S2) were resolved by SDS-PAGE. The portion of gel containing RPL3 was proteinase K-digested
and analyzed by MS. Shown are the mean relative intensities of MS signals, gates for different methylation states of the indicated, RPL3-derived peptide,
with His-245 marked in red. Three independent analyses of each cell line were performed. Error bars represent range of values. An asterisk indicates
that the relevant peptide was not detected. (B) MS/MS fragmentation spectra show monomethylation of RPL3 at His-245 in HAP1 WT cells (top) and
absence of methylation in METTL18 KO cells (bottom). (C and D) R246A/R249A-mutated RPL3 is monomethylated at His-245 in HEK293-derived
cells. Flp-In™ T-REx™ 293 (HEK293) cells expressing R246A/R249A-mutated RPL3-GFP under doxycycline-inducible promoter, were treated for 24 h
with doxycycline (1 g/ml) and the mutated RPL3-GFP fusion protein was isolated using GFP-Trap®, and resolved by SDS-PAGE. The portion of gel
corresponding to RPL3-GFP was Lys-C-digested and analyzed by MS. (C) Shown are representative, normalized extracted ion chromatograms, gated
for different methylation states of RPL3-derived, Lys-C-generated peptides, encompassing residues 244–250 of R246A/R249A-mutated RPL3, present in
cells, with His-245 marked in red. Percentages indicate the relative area under each peak. A.U., arbitrary units. (D) MS/MS fragmentation spectrum shows
monomethylation of R246A/R249A-mutated RPL3 at His-245 in HEK293-derived cells.
quantifying the observed changes (Figure 7B and C). We
found that the amount of 47S and 45S pre-rRNAs were sim-
ilar in WT and KO cells, indicating that METTL18 ablation
does not affect transcription and initial processing at sites
A’ and 02. However, we detected a significant decrease in
41S pre-rRNA as well as its precursor 41S+3’, concomitant
with an increase in 30S pre-rRNA in KO compared to WT
cells, whereas the levels of 32S, 21S and 12S pre-RNAs re-
mained unchanged (Figure 7B and C). These alterations in
30S and 41S rRNA levels suggest that cleavage at sites A0
and 1 is impaired in the KO cells (see ref. 25 for an out-
line of the pre-rRNA processing pathway in human cells).
The observed changes in these pre-rRNA intermediates in
METTL18 KO cells were, however, not accompanied by sig-
nificant changes in the steady-state levels of downstream
intermediates (21S, 18S-E) or of mature rRNAs, including
18S, 28S and 5.8S rRNAs, which were similar in WT and
KO cells (Figure 7C and D). This indicates that 5’-ETS pro-
cessing is not blocked, but rather slowed down in the KO
cells. In summary, the above results indicate that METTL18
ablation, and consequently lack of RPL3 monomethylation
at His-245, affects the dynamics of pre-rRNA processing,
but has no apparent effect on the amount of mature rRNAs.
METTL18 ablation affects translation dynamics
Methylation modification of human translation factors
has been shown to significantly affect mRNA translation
(35,50,51,56–58). Since we observed that METTL18 influ-
ences pre-rRNA processing, we reasoned that METTL18
may also influence other aspects of ribosome biogenesis and
impact on translation. Therefore, we investigated whether
the loss of METTL18 function affects mRNA translation.
First, we used HAP1 WT and METTL18 KO cells and
performed polysome profiling to assess global translation.
Polysome profiling uses sucrose-gradient centrifugation of
cytoplasmic extracts, to determine the amount of ribosomal
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Figure 5. METTL18 introduces 3MH modification in cellular RPL3. (A)
METTL18 KO abrogates 3MH modification in ribosomes. Whole cells
or ribosomes isolated from HAP1 WT or METTL18 KO cells were sub-
jected to HCl-mediated hydrolysis into amino acids, and the content of
His and 3MH was determined by LC-MS/MS. Shown is the average rela-
tive amount of 3MH detected in indicated cells and ribosomes, expressed
as percentage of total His. Error bars represent range of values from 3
(cells) or 4 (ribosomes) independent analyses. (B) METTL18 enzymatic ac-
tivity is specifically required for 3MH modification of RPL3. Ribosomes
isolated from HAP1 WT, METTL18 KO or KO cells expressing FLAG-
tagged METTL18, either non-mutated or D217A-mutated (see Supple-
mentary Figure S2) were resolved by SDS-PAGE. The region of gel con-
taining RPL3 was excised and subjected to amino acid analysis, as in (A).
Shown is the average relative amount of 3MH detected in RPL3, expressed
as percentage of total His. Error bars represent range of values from four
to five independent analyses.
served that the amount of 80S ribosomes was similar in WT
and METTL18 KO cells; however, the amounts of small
subunits (40S), large subunits (60S) and polysomes were
clearly decreased in the METTL18 KO (Figure 8A and B).
This indicates a defect in formation of 40S subunits, and
also suggests that KO cells have impaired translation ini-
tiation, i.e. loading of new ribosomes on mRNA, and/or
increased translation speed.
Second, to obtain a more detailed picture on transla-
tion dynamics, we performed ribosome profiling, a deep-
sequencing-based method to analyze transcriptome-wide
ribosome occupancy at sub-codon resolution. This allows
quantification of ribosomal A-site occupancy of individual
codons and determination of the relative translation rates
of individual codons between two conditions (43). Also, this
method can be used to assess translation at the gene level,
and we found cellular processes that are linked to RNA
metabolism, the cell cycle and metabolic processes to be
upregulated in METTL18 KO relative to WT cells (Figure
9A), while cell signaling-related GO terms were significantly
down-regulated (Figure 9B). We found that the relative A-
site occupancy of the majority of codons did not differ be-
tween METTL18 KO and WT cells (Figure 9C). However,
the codon GAA (Glu) showed a substantial increase in oc-
cupancy in METTL18 KO cells, i.e. corresponding to a de-
creased translation rate, whereas several codons showed de-
creased occupancy, i.e. corresponding to an increased trans-
lation rate, most markedly GGA (Gly) and GTT (Val) (Fig-
ure 9C). As a control, we also analyzed ribosome occupancy
at the codon downstream of the A-site (i.e. a codon that has
not yet been translated) and, reassuringly, we did not see any
appreciable differences between the METTL18 KO and WT
cells (Figure 9C). In summary, we found that METTL18 ab-
lation and lack of RPL3 monomethylation at His-245 led to
a global reduction of polysome formation and introduced
codon- and gene-specific changes in translation.
DISCUSSION
In the present work, we have firmly established that
METTL18 is a histidine-specific MTase, and that it cat-
alyzes the introduction of 3MH at His-245 in human RPL3.
Consistent with this function, we found that METTL18 lo-
calizes to nucleoli, the sites of ribosome maturation, and
that METTL18 KO affects rRNA maturation and mRNA
translation. Given that METTL18 KO cells are viable, also
in long-term culture, we conclude that METTL18 is a non-
essential protein, which likely serves a role in optimizing ri-
bosome biogenesis and function.
In general, MTF16 members appear to interact tightly
with their substrates, which in several cases were first iden-
tified through screens for MTase interactants (19,21,56,59).
This appears to be the case also for METTL18, because
RPL3 was previously identified as a METTL18 interac-
tant (18). Conversely, METTL18 was one of two annotated
MTases, among the top 74 strongly (>16-fold) enriched hits
in our RPL3 interactomics screen (Figure 3A and Supple-
mentary Table S6). In agreement with the apparent strong
affinity of METTL18 for its substrate, we found that recom-
binant METTL18 was able to methylate RPL3 in cellular
extracts. However, we were unable to detect enzymatic ac-
tivity of METTL18 on recombinant RPL3, and similar ob-
servations were made for yeast Hpm1, as well as for Rkm2, a
S. cerevisiae MTase that targets a ribosomal protein (10,60).
Interestingly, these MTases recognize their substrates only
in the context of a partially or fully assembled ribosome.
Given this mode of recognition, it seems less likely that
METTL18 has additional substrates. Indeed, we did not
detect methylation of proteins other than RPL3 when in-
cubating cellular extracts with METTL18. Nevertheless, it
cannot be excluded that additional substrates exist, e.g. low-
abundance proteins or substrates masked by the bands re-
sulting from automethylation in the extracts. Also, the ob-
served automethylation of METTL18 at His-154 may sug-
gest that this MTase has the potential to target histidines in
sequences other than the (herein) established target site in
RPL3. Studies of yeast Hpm1 have suggested the existence
of substrates other than Rpl3 (61), and it will be of interest
to investigate whether METTL18 has additional substrates
as well.
When His-243 in yeast Rpl3 was first reported as the tar-
get of Hpm1, the evidence was convincing, but indirect (10).
Rpl3 from Hpm1-deficient yeast showed a mass reduction
corresponding to the lack of a methyl group, and lacked a
methylated amino acid that co-eluted with 3MH in chro-
matography (10). No specific methylated histidine residue
was detected by MS of Rpl3 and its proteolytic fragments,
but His-243 was concluded to be the modification site be-
cause it was the only histidine residue present in the single
segment (amino acids 234–249) that was not covered by the
MS analysis (10). This initial study on Hpm1 was followed
up by excellent work that further corroborated Hpm1 as
a MTase introducing 3MH into Rpl3, but no direct (‘se-
quence specific’) MS evidence was presented to confirm
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Figure 6. METTL18 is monomethylated at His-154. (A) Recombinant and cellular METTL18 is monomethylated at His-154. Recombinant Escherichia
coli-expressed 94 METTL18, either WT or D217A-mutated, was resolved by SDS-PAGE and the portion of gel containing METTL18 was trypsin-
digested, and analyzed by MS. Alternatively, Flp-In™ T-REx™ 293 (HEK293) cells, expressing RPL3-GFP under doxycycline-inducible promoter, were
treated for 24 h with doxycycline (1 g/m). RPL3-GFP was isolated using GFP Trap®, trypsin-digested and co-purifying proteins were identified by MS,
similarly as in Figure 3A. Endogenous METTL18 was identified as an RPL3 interactant (see Figure 3A). Shown are the relative MS signals corresponding
to the unmetylated or monomethylated versions of the indicated, METTL18-derived peptide, with His-154 marked in red. Two (E. coli-derived METTL18)
or six (HEK293-derived METTL18) independent analyses were performed. Shown are the mean relative intensities of MS signals, and error bars represent
range of values. An asterisk indicates that the relevant peptide was not detected. (B) MS/MS fragmentation spectra show monomethylation of His-
154 in recombinant METTL18 WT (top) and absence of methylation in enzyme-inactive D217A-mutated METTL18 (bottom). (C) H154A mutation
inhibits METTL18-dependent methylation of RPL3. A total of 40 g of protein from nuclear fraction of HAP1 METTL18 KO cells was incubated with
[3H]AdoMet (0.5 Ci) and 94 METTL18 (3 M), either WT or H154A-mutated, and then analyzed by SDS-PAGE and transferred to a membrane.
Incorporation of [3H]-methyl into proteins was visualized by fluorography (top) of Ponceau S-stained membrane (bottom), shown as loading control.
Arrows indicate the position of automethylated METTL18 and the ∼46 kDa protein substrate, previously identified as RPL3.
an unconventional protease, proteinase K, and the ectopic
expression of a more ‘MS-friendly’ RPL3 mutant protein,
we were able to directly establish the corresponding residue
in human RPL3, His-245, as the target site of METTL18,
thus also further corroborating His-243 in Rpl3 as the tar-
get of Hpm1 in yeast.
Our results show that ablation of METTL18 yields an
accumulation of 30S pre-rRNA (precursor of 18S rRNA
of the small subunit), and a concomitant decrease of 41S
pre-rRNA (precursor of 5.8S and 28S rRNAs of the large
subunit) (Figures 7B and C). Similar changes in pre-rRNA
processing have been observed by others, and attributed to
defects in early processing of the 5′ ETS at cleavage sites
A0 and 1 (Figure 7A, and reviewed in ref. (25)). The ob-
served changes did not, however, affect the relative steady-
state levels of mature rRNAs (Figure 7D). This phenotype is
similar to that observed in yeast deficient in the METTL18
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Figure 7. Comparison of pre-rRNA processing in HAP1-derived cells. (A) A schematic view of the human rRNA primary transcript, 47S pre-rRNA (top)
and its maturation intermediates (bottom). The sequences corresponding to 18S (magenta), 28S (cyan) and 5.8S (gray) rRNAs are indicated, flanked by
external (5’ETS, 3’ETS) and internal (ITS1, ITS2) transcribed spacers indicated by solid black lines. Position of main endoribonuclease cleavage sites is
indicated by dotted gray lines. Short pre-5.8S precursors generated by exoribonuclease trimming of 12S pre-rRNA are shown enlarged in the inset. (B–D)
Steady-state pre-rRNA processing in WT and METTL18 KO cells. Total RNA was isolated from cells and separated on agarose gel, except for shorter
rRNAs (5S, 5.8S) that were separated on polyacrylamide gel and then northern-blotted on membrane, which was probed using indicated DNA probes (for
probe sequences, see Supplementary Table S2). (B) Visualization of pre-rRNA intermediates in WT and KO cells, detected as bands using indicated probes.
(C) Quantitation of changes in band intensities observed in KO relative to WT cells. Shown are mean values normalized to either 28S rRNA or 7SK RNA
(small non-coding RNA, not related to rRNA), with error bars representing S.D. (n = 3). (D) Visualization of 18S rRNA from small ribosomal subunit,
and 28S, 5.8S and 5S rRNAs from large ribosomal subunit, present in WT and KO cells. The 7SK is shown as loading control.
rRNAs containing non-cleaved 5′ ETS, but without signif-
icant changes in the relative amounts of mature rRNAs. In
particular, the Hpm1-deficient yeast strain showed accumu-
lation of 35S (primary transcript) and 23S (precursor of 18S
rRNA from small subunit) pre-rRNAs, corresponding to
human 47S and 30S pre-rRNAs, respectively (23,61). Thus,
ablation of Rpl3 histidine methylation has a similar effect
on pre-rRNA processing in human and yeast cells.
However, some features of ribosomal assembly appear
to be differently affected by METTL18 and Hpm1 KO.
METTL18 KO cells show a reduced 40S/80S subunit ra-
tio, and also a reduced amount of polysomes, while the ra-
tio of 60S/80S is not significantly affected (Figures 8A and
B). This suggests a slight deficit of 40S subunits in cells
lacking METTL18, which is in line with observed pertur-
bation in 5′ ETS processing of pre-rRNA resulting in accu-
mulation of 30S pre-rRNA (Figures 7B and C). In contrast,
Hpm1-deficient yeast displayed reduced levels of 60S sub-
units, but no significant changes in polysome level (23,61).
It was suggested that Hpm1 has substrates other than
Rpl3, and concluded that some of the phenotypes of Hpm1
KO are related to methylation of these, yet unidentified,
non-Rpl3 substrates (61). Conceivably, differences regard-
ing non-Rpl3 methylation may also underlie some of the
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Figure 8. METTL18 ablation results in altered polysome profiles in HAP1-derived cells. (A) Polysome profiles of cytoplasmic fractions from WT and
METTL18 KO cells. Cytoplasmic fraction was isolated from indicated cells, centrifuged in 10–50% sucrose gradient and OD254nm was measured across the
gradient to show the distribution of small (40S) and large (60S) ribosomal subunits, monosomes (80S) and polysomes. Shown are representative profiles
for WT (solid black) and METTL18 KO (dashed gray) cells, out of four independent experiments. (B) Quantitation of relative amounts of 40S, 60S, 80S
and polysomes observed in WT and METTL18 KO cells, based on four replicates of polysome profiles obtained as in (A). Blue whiskers represent SD.
In our ribosomal profiling experiments, the codon GAA
(Glu) stood out, showing a dramatic increase in occu-
pancy (Figure 9C). Interestingly, we recently performed
similar experiments on cells devoid of the 28S rRNA spe-
cific N6-adenosine MTase, ZCCHC4, and we also ob-
served the highest increase in occupancy for the GAA
codon (32). Moreover, the two codons (GGA and GTT)
that showed the strongest decrease in occupancy in the
METTL18 KO cells, were also among the ones that were
mostly decreased in ZCCHC4 KO cells. One may there-
fore speculate that certain codon/tRNA interactions are
particularly sensitive to perturbations of the ribosome, e.g.
through abolishment of methyl modifications. Of note, al-
though we observed codon-specific changes during trans-
lation in cells lacking MTases targeting the key transla-
tion factor eEF1A, these alterations in codon occupancy
were very distinct from those observed in cells lacking
METTL18 and ZCCHC4 (32,50,51). Regarding the strong
increase in occupancy at GAA, one study highlighted the
codon pair GCA-GAA as being strongly underrepresented
in humans (62). This study also provided expected ver-
sus observed frequencies for all 3721 (61 × 61) codon
pairs, and we plotted these data grouped by the last codon
of the codon pair. Intriguingly, the GAA-ending codon
pairs clearly stood out as encompassing a large fraction of
the under-represented codon pairs (Figure 9D). Interest-
ingly, AA-ending codons (AAA, CAA, GAA) have previ-
ously been characterized as ‘difficult’ codons, whose trans-
lation is particularly dependent on the presence of wob-
ble uridine modifications in tRNA (45,63). Correspond-
ingly, our present (METTL18) and previous (ZCCHC4)
data suggest that absence of ribosome modifications can
cause stalling at the GAA codon in the A-site, and we fur-
ther speculate that the strong under-representation of cer-
tain GAA-ending codon pairs may reflect that GAA is a
‘challenging’ codon for the translation apparatus. An al-
ternative explanation for the similar codon-specific phe-
notypes of METTL18 and ZCCHC4 KO cells could be
that the abrogation of METTL18-mediated RPL3 methy-
lation somehow affects ZCCHC4-mediated 28S rRNA
methylation, or vice versa, but we consider this less
likely.
RPL3 is arguably one of the most important and most-
studied eukaryotic ribosomal proteins. It is universally
present in organisms from all three domains of life, as in-
dicated by its alternative name, ‘uL3’. Furthermore, RPL3
is localized in the vicinity of the peptidyltransferase center
(PTC) inside the ribosomes, interacting with the so-called
aminoacyl-tRNA accommodation corridor (Figure 10A)
(64). Current insights into the role of RPL3 in ribosome
function mainly stem from studies in yeast, which suggest
that Rpl3 plays an important role in intra-ribosome com-
munication by allosterically transmitting the ribosome’s
tRNA occupancy status to the elongation factor bind-
ing region and the PTC (64). Interestingly, the Hpm1 tar-
get site in yeast Rpl3 is localized within the so-called ba-
sic thumb, which appears to act as a rocker switch dur-
ing such communication (61,64). Importantly, yeast Rpl3
and human RPL3 are very similar (66% sequence iden-
tity) and the sequence of the basic thumb (residues 234–
246 in human RPL3) is identical, while the histidine tar-
geted by METTL18/Hpm1 (His-245/His-243, respectively)
shows a virtually identical orientation in the structures
of the human and yeast ribosomes (Figure 10B). This
agrees well with our observation that ablation of METTL18
gave similar effects on pre-rRNA processing to those ob-
served in Hpm1-deficient yeast cells. Taken together, this
indicates that both METTL18-mediated methylation of
RPL3 and its functional role are conserved from yeast to
humans.
The role of RPL3 in ribosome biogenesis and function
has not been extensively investigated in mammals or other
metazoans. However, a high-throughput study, which as-
sessed the effects of individual knockdown (by RNAi) of
all the 80 human ribosomal proteins, reported that RPL3
knockdown negatively affected the early to intermediate
cleavage steps leading to the formation of 28S rRNA (65).
Furthermore, an important ‘extra-ribosomal’ role for hu-
man RPL3 has been established through a number of stud-
ies [reviewed in (66)]. If ribosome biogenesis in nucleoli is
disturbed, e.g. by drugs or metabolic stress, ribosome-free
RPL3 will be released and will accumulate in the nucleus,
where it acts as a transcription factor (67,68). Ribosome-
free RPL3 can have a multitude of effects, including the in-
duction of G1 arrest and inhibition of apoptosis (66,67).
Moreover, the genomes of humans and other vertebrates
encode a RPL3 paralog, denoted RPL3-like (RPL3L), with
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Figure 9. METTL18 ablation results in altered translation in HAP1-derived cells. (A) GO term analysis (Cellular Process) of genes significantly upregulated
on the footprint level in METTL18 KO cells relative to WT cells. Number of genes matching the respective GO term category is indicated in brackets. (B)
Similar as in (A) but for downregulated genes. (C) The relative ribosome occupancy of mRNA codons in METTL18 KO cells relative to WT cells. The
occupancy at acceptor (A-site) is shown in red, and the occupancy at downstream, not yet translated, codon (+1-site) is shown in gray. Spread of data is
indicated by horizontal whiskers (mean ± SD, n = 3). Circle size indicates the relative frequency of codons in quartiles (larger is more frequent). (D) GAA
is frequently found as the second codon in underrepresented codon pairs. Shown are the observed versus the expected frequencies, expressed as the natural
logarithm, of the 3721 (61 × 61) codon pairs present in the human ORFeome. The codon pairs are grouped according to the identity of the second codon.
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Figure 10. Localization of His-245 in RPL3 in the ribosome structure. (A) His-245 in RPL3 is localized close to the PTC of the human ribosome. Helices
89 (H89; red) and 90/91 (H90/91; blue) in rRNA form the corridor (purple dotted arrow) that channels aminoacyl-tRNA to the PTC, which is indicated
by yellow coloring of the key catalytic residue A4397 in 28S rRNA (corresponding to A2451 in Escherichia coli 23S rRNA and to A2820 in Saccharomyces
cerevisiae 25S rRNA). His-245 (purple) in RPL3 (green) is localized to the so-called basic thumb, which interacts with H90/91. H95 (orange) represents
the ‘sarcin-ricin loop’ (which is subject to cleavage by certain plant toxins). The figure has been adapted from similar figures that were based on the S.
cerevisiae ribosome (61,64). (B) His-243 (cyan) in yeast Rpl3 (beige) and His-245 (purple) in human RPL3 (green) show a near-identical orientation. The
figure was made using PyMOL Molecular Graphics System, version 1.3 (Schrödinger, LLC), and available structures of the yeast (PDB ID: 4V7R) and
human (PDB ID: 4UG0) ribosomes (72,73).
a reported ability to repress myotube formation in muscle
cells (69,70). In future studies, it will be of interest to inves-
tigate how METTL18-mediated histidine methylation in-
fluences canonical and extra-ribosomal functions of RPL3
and RPL3L.
Less than a decade ago, none of the human MTF16
members had been functionally characterized. Notably,
with the current investigation, enzymatic activities have
now been reported for all 11 enzymes, and their collec-
tive substrate specificity has, by the present work, been
expanded to also encompass histidine methylation. The
first human histidine-specific MTase was uncovered only
recently, when it was shown that SETD3 was the long-
sought MTase responsible for introducing 3MH into His-
73 in actin (8,11). Thus, METTL18 represents the second
human MTase to be discovered. So far, histidine methy-
lation has been firmly demonstrated for only a handful
of mammalian proteins. However, these proteins partic-
ipate in a wide range of biochemical and cellular pro-
cesses, and high-throughput proteomic analyses have indi-
cated the presence of histidine methylation in hundreds of
proteins (11,17). Thus, protein histidine methylation holds
promise as a very interesting and fruitful field of future
research, which is likely to yield important insights into
how protein function is optimized and regulated by this
modification.
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